Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C and Methenamine Hippurate in Recurrent UTIs
NCT06710899Phase 1Not yet recruiting
- Sponsor
- University Hospital of North Midlands
- Start
- Jan 2027
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ascorbic acid in urinary tract infection (UTI) (3 arms), sponsored by University Hospital of North Midlands. Primary endpoint: Frequency of Urinary Tract Infections at 24 months. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
ascorbic acid
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT06710899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06710899.